ABSTRACT The unique pharmacokinetics of BRAF and MEK inhibitors make patients vulnerable to drug–drug interactions (DDIs), which may compromise treatment efficacy in metastatic melanoma. This study evaluates the impact of DDIs on clinical outcomes in patients with metastatic melanoma treated with BRAF/MEK inhibitors.
Silvia Mezi+14 more
wiley +1 more source
Clinical and electrophysiological features of adult patients with combined central and peripheral demyelination- a systematic review. [PDF]
Andrusiów S+2 more
europepmc +1 more source
Breakdown of C3 complement and IgG in peritonitis exudate-pathophysiological aspects and therapeutic approach [PDF]
Billing, A.+5 more
core
ABSTRACT Xenotransplantation is becoming an emerging field of interest for the treatment of end‐stage heart disease. In fact, the shortage of human heart donors in European countries requires the increasing investigation of alternative strategies such as heart xenotransplantation.
Nicola Pradegan+6 more
wiley +1 more source
50 years of methylprednisolone application in spinal cord injury: a bibliometric analysis. [PDF]
Zhou M+6 more
europepmc +1 more source
The efficacy of methylprednisolone acetate nanogel in treating patients with sudden sensorineural hearing loss. [PDF]
Amizadeh M+3 more
europepmc +1 more source
RETRACTION: Clinical Efficacy of Flap Transplantation Combined With Vacuum Sealing Drainage and Methylprednisolone and Cyclosporine in the Treatment of Pyoderma Gangrenosum. [PDF]
europepmc +1 more source
Generalized Pustular Psoriasis with Cushing's Syndrome: A Case of Effective Spesolimab Treatment. [PDF]
Peng G+8 more
europepmc +1 more source
Comparison of methylprednisolone alone versus intravenous immunoglobulin plus methylprednisolone for multisystem inflammatory syndrome in children (MIS-C). [PDF]
Phan PH+5 more
europepmc +1 more source
The Effects of Methylprednisolone and Hyaluronic Acid on the Endometrium in Experimentally Induced Asherman Syndrome Rat Models: A Prospective Laboratory Study. [PDF]
Genco M, Genco M, Vural F, Koç N.
europepmc +1 more source